1. Cancer and the Immune System: The History and Background of Immunotherapy;Abbott;Semin Oncol. Nurs.,2019
2. Academic, Community Cancer Research U., National Cancer I. Nivolumab and Brentuximab Vedotin in Treating Older Patients With Untreated Hodgkin Lymphoma 2019 [updated August 13. Available from: 〈https://ClinicalTrials.gov/show/NCT02758717〉.
3. Immune-related adverse events (irAE) in cancer immune checkpoint inhibitors (ICI) and survival outcomes correlation: to rechallenge or not?;Albandar;Cancers,2021
4. Pediatric lymphomas and histiocytic disorders of childhood;Allen;Pediatr. Clin.,2015
5. Allison J., Krummel M., Leach D. Enhancement of Antitumor Immunity by CTLA-4 Blockade. science.271:1734.